Short-term effects of NPH insulin, insulin detemir, and insulin glargine on the GH-IGF1-IGFBP axis in patients with type 1 diabetes.
Ma, Zhulin
Short-term effects of NPH insulin, insulin detemir, and insulin glargine on the GH-IGF1-IGFBP axis in patients with type 1 diabetes. [electronic resource] - European journal of endocrinology Oct 2014 - 471-9 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1479-683X
10.1530/EJE-14-0258 doi
Adult
Area Under Curve
Blood Glucose--metabolism
Cross-Over Studies
Diabetes Mellitus, Type 1--blood
Female
Human Growth Hormone--blood
Humans
Hypoglycemic Agents--administration & dosage
Injections, Subcutaneous
Insulin Detemir
Insulin Glargine
Insulin, Isophane--administration & dosage
Insulin, Long-Acting--administration & dosage
Insulin-Like Growth Factor Binding Protein 2--blood
Insulin-Like Growth Factor Binding Protein 3--blood
Insulin-Like Growth Factor Binding Proteins--blood
Insulin-Like Growth Factor I--drug effects
Linear Models
Male
Middle Aged
Time Factors
Treatment Outcome
Short-term effects of NPH insulin, insulin detemir, and insulin glargine on the GH-IGF1-IGFBP axis in patients with type 1 diabetes. [electronic resource] - European journal of endocrinology Oct 2014 - 471-9 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1479-683X
10.1530/EJE-14-0258 doi
Adult
Area Under Curve
Blood Glucose--metabolism
Cross-Over Studies
Diabetes Mellitus, Type 1--blood
Female
Human Growth Hormone--blood
Humans
Hypoglycemic Agents--administration & dosage
Injections, Subcutaneous
Insulin Detemir
Insulin Glargine
Insulin, Isophane--administration & dosage
Insulin, Long-Acting--administration & dosage
Insulin-Like Growth Factor Binding Protein 2--blood
Insulin-Like Growth Factor Binding Protein 3--blood
Insulin-Like Growth Factor Binding Proteins--blood
Insulin-Like Growth Factor I--drug effects
Linear Models
Male
Middle Aged
Time Factors
Treatment Outcome